- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0192986

Medoxa Pharmaceutical Private Limited
About Medoxa Pharmaceutical Private Limited
Data last updated:
Medoxa Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC361531. Its GSTIN is 27AAOCM6495J1ZM (Maharashtra).
The company has an authorised share capital of ₹10,000 and a paid-up capital of ₹10,000. It is led by directors Shivkant Kashinath Khetan and Ramchandra Tirthraj Prajapati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.99 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net profit of ₹45,944 (net margin 5.1%) and EBITDA of ₹1.51 Lakh (EBITDA margin 16.8%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years.
Medoxa Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0192986).
Company details
Recognitions & Rankings of Medoxa Pharmaceutical
Contact details
Medoxa Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address2 Shri Satya Sai Deep Chs Plot No. 30 Andheri Kurla Road J.B. Nagar Andheri, (East), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medoxa Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medoxa Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medoxa Pharmaceutical Private Limited, buy the company report.
Financials of Medoxa Pharmaceutical Private Limited
FY 2025 filings availableMedoxa Pharmaceutical Private Limited reported revenue of ₹8.99 Lakh (down 93% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 46% over three years, including a 93% fall in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.51 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹45,944 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 16.8% | |||
| Net Profit Margin | 5.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medoxa Pharmaceutical Private Limited, buy the company report.
Board of directors of Medoxa Pharmaceutical Private Limited
Medoxa Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivkant Kashinath Khetan Also directs: Chavo Textile Private Limited, Priyavrat Textiles Private Limited | Director | 03 Jun 2021 | 5 Years 5 Months | Current |
| Ramchandra Tirthraj Prajapati Also directs: Medily Prime Private Limited, 3S Healthcare Private Limited | Director | 03 Jun 2021 | 5 Years 5 Months | Current |
Peer comparison
Medoxa Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| S.P. Property Private Limited | ₹9 Lakh (FY 2017) | Ahmedabad, Gujarat, India | ||||
| Umra Gold & Silver Private Limited | ₹9 Lakh (FY 2025) | 1352.0% | Kolkata, West Bengal, India | |||
| Gerald Industries Private Limited | ₹9 Lakh (FY 2025) | -68.0% | Idukki, Kerala, India | |||
| Indivillage Crafts Private Limited | ₹9 Lakh (FY 2025) | -8.0% | Hyderabad, Telangana, India | |||
| Bhalotia Global Ventures Private Limited | ₹8.99 Lakh (FY 2024) | 535.0% | Jamshedpur, Jharkhand, India | |||
| Medoxa Pharmaceutical Private Limitedthis company | ₹8.99 Lakh (FY 2025) | ₹45,944 | 5.1% | -93.0% | Mumbai, Maharashtra, India | |
| Omkam Global Capital Private Limited. | ₹8.99 Lakh (FY 2025) | 31.0% | New Delhi, Delhi, India | |||
| Treownovative Private Limited | ₹8.99 Lakh (FY 2020) | 38.0% | Gorakhpur, Uttar Pradesh, India | |||
| Saubhagya Auto Dealers Private Limited | ₹8.98 Lakh (FY 2024) | 9.0% | Delhi, India | |||
| Haddock Global Private Limited | ₹8.98 Lakh (FY 2025) | -46.0% | Tirur, Kerala, India | |||
| N.P.S. Industries Private Limited | ₹8.98 Lakh (FY 2025) | -34.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Medoxa Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medoxa Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medoxa Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medoxa Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
Medoxa Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCM6495J1ZM | Maharashtra | Active | 25 Jun 2021 |
To see the full GST registrations and return filing status of Medoxa Pharmaceutical Private Limited, buy the company report.
Recent activity
Medoxa Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ramchandra Tirthraj Prajapati was appointed as Director on 03 Jun 2021.
Frequently asked questions
Medoxa Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 June 2021 (5+ years old) and is registered under CIN U51909MH2021PTC361531.
Medoxa Pharmaceutical has 2 current directors:
- Shivkant Kashinath Khetan - Director
- Ramchandra Tirthraj Prajapati - Director
The latest financial statements of Medoxa Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Medoxa Pharmaceutical is 27AAOCM6495J1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medoxa Pharmaceutical is U51909MH2021PTC361531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medoxa Pharmaceutical was incorporated on 03 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medoxa Pharmaceutical by revenue are S.P. Property Private Limited, Umra Gold & Silver Private Limited, Gerald Industries Private Limited, Indivillage Crafts Private Limited, Bhalotia Global Ventures Private Limited and 5 more, all in the same principal business activity (retail trading).
Ramchandra Tirthraj Prajapati was appointed as Director on 03 Jun 2021. Shivkant Kashinath Khetan was appointed as Director on 03 Jun 2021.
Yes, Medoxa Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0192986).
The registered office of Medoxa Pharmaceutical is at 2 Shri Satya Sai Deep Chs Plot No. 30 Andheri Kurla Road J.B. Nagar Andheri, East, Mumbai, Maharashtra, India – 400059.
Medoxa Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

